Lupus News From Medical News Today Latest Health News and Medical News posted throughout the day, every day.
Psychotherapy May Help Autoimmune Disease
This study shows that cognitive behavioural therapy (CBT) is effective in dealing with patients suffering from lupus and high levels of daily stress as it significantly reduces the incidence of psychological disorders associated with lupus and improves and maintains patients' QOL, despite there being no significant reduction in the disease activity index...
Antibodies Linked To Cardiovascular Disease Increase In Patients With Active Lupus
A study by researchers in Australia and the United Kingdom suggests that autoantibodies to fat binding proteins significantly increase in systemic lupus erythematosus (SLE) patients with active disease...
Testing For Urinary Proteins Might Help Diagnose Kidney Damage From Lupus
Simple urine tests for four proteins might be able to detect early kidney disease in people with lupus, researchers at UT Southwestern Medical Center have found in an animal study. Although it might take years before such tests could be used clinically, the findings suggest they could pinpoint kidney disease better than tests currently in use, the researchers said...
LFA President Presents At The 12th Annual BIO CEO And Investor Conference
During the 12th Annual BIO CEO and Investor Conference held on Tuesday, February 9, 2010 in New York City, Sandra C. Raymond, President and CEO of the Lupus Foundation of America (LFA), participated in a panel discussion on the future of potential new treatments for lupus. The conference was hosted by BIO, the international umbrella organization for international biotechnology companies...
TAU Expert Reviews Environmental Triggers (hairspray! Lipstick!) Of Common Autoimmune Diseases
The links between autoimmune diseases, infections, genetics and the environment are complex and mysterious...
New Therapeutic Approach Identified For Kidney Disease Associated With Lupus
Investigators have identified a new disease mechanism and therapeutic approach for a type of advanced kidney disease that is a common cause of complications in patients with lupus. The study was led by investigators at Hospital for Special Surgery and appears in the January 25 online Early Edition of the Proceedings of the National Academy of Sciences...
The Lupus Foundation Of America Seeks Applications For Its 2010 Gina M. Finzi Memorial Student Summer Fellowship Program
The Lupus Foundation of America, Inc. (LFA) is seeking applications for its 2010 Gina M. Finzi Memorial Student Summer Fellowship Program. The purpose of these awards is to foster an interest among young investigators in lupus research under the supervision of an established in investigator...
Epratuzumab Receives U.S. Patent - Lupus Foundation Of America, Inc.
A U.S. patent has been issued to Immunomedics, Inc. for epratuzumab, a monoclonal antibody under development as a potential new treatment for lupus. In August of 2009, Immunomedics and its partner, UCB of Belgium, reported promising data from a phase IIb clinical study of epratuzumab involving 227 individuals with moderate to severe lupus. Learn more about these results...
Genomes Of Identical Twins Reveal Epigenetic Changes That May Play Role In Lupus
Identical twins look the same and are nearly genetically identical, but environmental factors and the resulting cellular changes could cause disease in one sibling and not the other. In a study published online in Genome Research (www.genome...
Julian Lennon And James Scott Cook Raise Awareness And Funds For Lupus Research
Julian Lennon, son of the legendary John Lennon, and James Scott Cook announced today that they will donate a portion of the proceeds from their song, "LUCY," to fund research on the disease lupus...
$3.6 Million Awarded To Drive Innovative Science In Lupus And Autoimmunity
The Lupus Research Institute (LRI) has named 12 new grant recipients for 2009. The awards, totaling $3.6 million, recognize innovative work across a broad spectrum of lupus research. All were selected for their creativity, novelty, and potential to drive scientific discovery to ultimately prevent, treat, and cure the complex disease of systemic lupus...
ImmuPharma Announces Final Results Of PhaseIIb Study Of LUPUZORâ„¢ In Lupus
ImmuPharma PLC announced the final results from a Phase IIb trial of LUPUZORâ„¢ in active patients with Systemic Lupus Erythematosus (SLE). Lupuzorâ„¢ administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care...
Saliva Proteins Change As Women Age
In a step toward using human saliva to tell whether those stiff joints, memory lapses, and other telltale signs of aging are normal or red flags for disease, scientists are describing how the protein content of women's saliva change with advancing age...
ImmuPharma PLC: Encouraging Final Phase IIb Results Seen With LUPUZORâ„¢ In Systemic Lupus Erythematosus
ImmuPharma PLC (LSE:IMM) the specialist discovery and development pharmaceutical company is pleased to announce the final results from a Phase IIb trial of LUPUZORâ„¢ in active patients with Systemic Lupus Erythematosus (SLE)...
Smokers With Common Autoimmune Disorder At Higher Risk For Skin Damage
As if there weren't enough reasons to stop smoking, a team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) have just found another. A study led by Dr. Christian A Pineau, Co-Director of the Lupus and Vasculitis clinic at the MUHC, has clearly linked skin damage and rashes to smoking in people with systemic lupus erythematosus (SLE)...
Promise Of A New Lupus Treatment Is A Groundbreaking Achievement
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTAâ„¢ (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology...
Lupus Research Institute: Benlysta(TM) Trial Results In An Historic Research Breakthrough And Victory For People With Lupus
The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences (HGS) and GlaxoSmithKline for achieving an historical landmark - the second positive phase 3 clinical trial of Benlysta (belimumab), the first successfully tested new drug developed specifically for people with systemic lupus...
BENLYSTAâ„¢ Successful In Second Pivotal Clinical Trial
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTAâ„¢ (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology...
Lupus Patients Who Receive Kidney Transplants Rarely Develop Lupus Nephritis
Individuals with a history of lupus who receive a kidney transplant rarely develop the serious inflammatory condition lupus nephritis in their new organ, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA...
Cellular Mechanism That Causes Lupuslike Symptoms In Mice Identified By Stanford Study
Macrophages, the scavenger cells of the body's immune system, are responsible for disposing of dying cells. Stanford University School of Medicine researchers have identified one pathway in this important process in mice that, if disrupted, causes a lupuslike autoimmune disease...
Lupus Patients Perceive Benefit From Cardiovascular Disease Prevention Counseling Program
According to a new study by Hospital for Special Surgery investigators presented at the American College of Rheumatology meeting on October 21 in Philadelphia, most lupus patients are not aware that their condition puts them at a higher risk for cardiovascular disease and a counseling program is a valuable way to promote education and lifestyle change...
National Report Shines Light On Lupus 50-Year Treatment Drought
The Lewin Group, a national health care consulting firm, has issued recommendations on ways to overcome the barriers that have obstructed lupus drug development resulting in no new drug approval for this disease in more than 50 years - since the Eisenhower Administration...
The Lupus Foundation Of America Urges Key Stakeholders To Implement Report Recommendations
The Lewin Group, a national health care consulting firm, issued recommendations on ways to overcome the barriers that have obstructed lupus drug development resulting in no new drug approval for this disease in more than 50 years- since the Eisenhower Administration...
Young Women With Autoimmune Condition Need To Be Warned About The Dangers Of Smoking And Use Of Oral Contraceptives
An article published Online First and in the November edition of The Lancet Neurology reports that women with a particular subtype of antibody called lupus anticoagulant (LA) have a more than 40-fold increased risk of stroke. Moreover, they have a 5-fold increased risk of heart attack compared with the general population of young women...
The Lupus Foundation Of America, Inc. Asks Supporters To Band Together For Lupus
It's been 50 years since the U.S. Food and Drug Administration (FDA) approved a medication to treat lupus -- when Dwight D. Eisenhower was President! To highlight the need for safer, more tolerable, and effective medications, the Lupus Foundation of America, Inc...
Worlds Best Pharmacy
canadian meds shop
Why is your product so cheap? How do you ship orders? We accept : Visa, MasterCard, AmEx, Diners and JCB cards. |
